|
|
|
|
AM Gardner, RR Vaillancourt, CA Lange-Carter and GL Johnson
Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.
MEK-1 is a dual threonine and tyrosine recognition kinase that phosphorylates and activates mitogen-activated protein kinase (MAPK). MEK-1 is in turn activated by phosphorylation. Raf and MAPK/extracellular signal-regulated kinase kinase (MEKK) independently phosphorylate and activate MEK-1. Recombinant MEK-1 is also capable of autoactivation. Purified recombinant wild type MEK-1 and a mutant kinase inactive MEK-1 were used as substrates for MEKK, Raf, and autophosphorylation. MEK-1 phosphorylation catalyzed by Raf, MEKK, or autophosphorylation resulted in activation of MEK-1 kinase activity measured by phosphorylation of a mutant kinase inactive MAPK. Phosphoamino acid analysis and peptide mapping identified similar MEK-1 tryptic phosphopeptides after phosphorylation by MEK kinase, Raf, or MEK-1 autophosphorylation. MEK-1 is phosphorylated by MAPK at sites different from that for Raf and MEKK. Phosphorylation of MEK-1 by MAPK does not affect MEK-1 kinase activity. Several phosphorylation sites present in MEK-1 immunoprecipitated from 32P-labeled cells after stimulation with epidermal growth factor were common to the in vitro phosphorylated enzyme. The major site of MAPK phosphorylation in MEK-1 is threonine 292. Mutation of threonine 292 to alanine eliminates 90% of MAPK catalyzed phosphorylation of MEK-1 but does not influence MEK-1 activity. The results demonstrate that MEKK and Raf regulate MEK-1 activity by phosphorylation of common residues and thus, two independent protein kinases converge at MEK-1 to regulate the activity of MAPK.
This article has been cited by other articles:
![]() |
S. Miyamoto, Y. Yasui, T. Tanaka, H. Ohigashi, and A. Murakami Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice Carcinogenesis, May 1, 2008; 29(5): 1057 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jimenez-Sanchez, V. J. Cid, and M. Molina Retrophosphorylation of Mkk1 and Mkk2 MAPKKs by the Slt2 MAPK in the Yeast Cell Integrity Pathway J. Biol. Chem., October 26, 2007; 282(43): 31174 - 31185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kumar, H. Yu, R. Edwards, L. Chen, S. Kazianis, P. Brafford, G. Acs, M. Herlyn, and X. Xu Mutant V600E BRAF Increases Hypoxia Inducible Factor-1{alpha} Expression in Melanoma Cancer Res., April 1, 2007; 67(7): 3177 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Harding, V. Hsu, K. Kornfeld, and J. F. Hancock Identification of Residues and Domains of Raf Important for Function in Vivo and in Vitro J. Biol. Chem., November 14, 2003; 278(46): 45519 - 45527. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gopalbhai, G. Jansen, G. Beauregard, M. Whiteway, F. Dumas, C. Wu, and S. Meloche Negative Regulation of MAPKK by Phosphorylation of a Conserved Serine Residue Equivalent to Ser212 of MEK1 J. Biol. Chem., February 28, 2003; 278(10): 8118 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hsu, C. L. Zobel, E. J. Lambie, T. Schedl, and K. Kornfeld Caenorhabditis elegans lin-45 raf Is Essential for Larval Viability, Fertility and the Induction of Vulval Cell Fates Genetics, February 1, 2002; 160(2): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sharma, Veeranna, M. Sharma, N. D. Amin, R. K. Sihag, P. Grant, N. Ahn, A. B. Kulkarni, and H. C. Pant Phosphorylation of MEK1 by cdk5/p35 Down-regulates the Mitogen-activated Protein Kinase Pathway J. Biol. Chem., January 4, 2002; 277(1): 528 - 534. [Abstract] [Full Text] |
||||
![]() |
Z. Li, X. Xi, and X. Du A Mitogen-activated Protein Kinase-dependent Signaling Pathway in the Activation of Platelet Integrin alpha IIbbeta 3 J. Biol. Chem., November 2, 2001; 276(45): 42226 - 42232. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pearson, F. Robinson, T. Beers Gibson, B.-e Xu, M. Karandikar, K. Berman, and M. H. Cobb Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions Endocr. Rev., April 1, 2001; 22(2): 153 - 183. [Abstract] [Full Text] |
||||
![]() |
D. Zella, F. Romerio, S. Curreli, P. Secchiero, C. Cicala, D. Zagury, and R. C. Gallo IFN-{alpha}2b Reduces IL-2 Production and IL-2 Receptor Function in Primary CD4+ T Cells J. Immunol., March 1, 2000; 164(5): 2296 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-e Xu, J. L. Wilsbacher, T. Collisson, and M. H. Cobb The N-terminal ERK-binding Site of MEK1 Is Required for Efficient Feedback Phosphorylation by ERK2 in Vitro and ERK Activation in Vivo J. Biol. Chem., November 26, 1999; 274(48): 34029 - 34035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dang, J. A. Frost, and M. H. Cobb The MEK1 Proline-rich Insert Is Required for Efficient Activation of the Mitogen-activated Protein Kinases ERK1 and ERK2 in Mammalian Cells J. Biol. Chem., July 31, 1998; 273(31): 19909 - 19913. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Aplin, A. Howe, S. K. Alahari, and R. L. Juliano Signal Transduction and Signal Modulation by Cell Adhesion Receptors: The Role of Integrins, Cadherins, Immunoglobulin-Cell Adhesion Molecules, and Selectins Pharmacol. Rev., June 1, 1998; 50(2): 197 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gerwins, J. L. Blank, and G. L. Johnson Cloning of a Novel Mitogen-activated Protein Kinase Kinase Kinase, MEKK4, That Selectively Regulates the c-Jun Amino Terminal Kinase Pathway J. Biol. Chem., March 28, 1997; 272(13): 8288 - 8295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Siow, G. B. Kalmar, J. S. Sanghera, G. Tai, S. S. Oh, and S. L. Pelech Identification of Two Essential Phosphorylated Threonine Residues In the Catalytic Domain of Mekk1. INDIRECT ACTIVATION BY Pak3 AND PROTEIN KINASE C J. Biol. Chem., March 21, 1997; 272(12): 7586 - 7594. [Abstract] [Full Text] [PDF] |
||||
![]() |
GregoryP. Downey, JeffreyR. Butler, J. Brumell, N. Borregaard, L. Kjeldsen, AndreaK. Sue-A-Quan, and S. Grinstein Chemotactic Peptide-induced Activation of MEK-2, the Predominant Isoform in Human Neutrophils. INHIBITION BY WORTMANNIN J. Biol. Chem., August 30, 1996; 271(35): 21005 - 21011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Johnson, S. Fenton, and L. G. Sheffield Prolactin Inhibits Epidermal Growth Factor-induced Ras-MAPK Signaling in Mammary Epithelial Cells J. Biol. Chem., August 30, 1996; 271(35): 21574 - 21578. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Winston, L. K. Remigio, and D. W. H. Riches Preferential Involvement of MEK1 in the Tumor Necrosis Factor-alpha-induced Activation of p42[IMAGE] in Mouse Macrophages J. Biol. Chem., November 17, 1995; 270(46): 27391 - 27394. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yamamori, S. Kuroda, K. Shimizu, K. Fukui, T. Ohtsuka, and Y. Takai Purification of a Ras-dependent Mitogen-activated Protein Kinase Kinase Kinase from Bovine Brain Cytosol and Its Identification as a Complex of B-Raf and 14-3-3 Proteins J. Biol. Chem., May 19, 1995; 270(20): 11723 - 11726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lange-Carter and G. Johnson Ras-dependent growth factor regulation of MEK kinase in PC12 cells Science, September 2, 1994; 265(5177): 1458 - 1461. [Abstract] [PDF] |
||||
![]() |
M. Karandikar, S. Xu, and M. H. Cobb MEKK1 Binds Raf-1 and the ERK2 Cascade Components J. Biol. Chem., December 15, 2000; 275(51): 40120 - 40127. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. J. Schroder, D. Pfeil, B. Opitz, K. S. Michelsen, J. Amberger, U. Zahringer, U. B. Gobel, and R. R. Schumann Activation of Mitogen-activated Protein Kinases p42/44, p38, and Stress-activated Protein Kinases in Myelo-monocytic Cells by Treponema Lipoteichoic Acid J. Biol. Chem., March 23, 2001; 276(13): 9713 - 9719. [Abstract] [Full Text] [PDF] |
||||